Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
Hire Dr. Melisa S.
United States

Clinical Researcher and Scientist

Profile Summary
Subject Matter Expertise
Services
Work Experience

Safety Reporting Administrator

Pharmaceutical Product Development Inc

July 2017 - Present

Freelance translator Spanish-English

Cactus Communications Inc

March 2017 - Present

Clinical Research Associate

Pharmaceutical Product Development Inc

July 2019 - July 2021

Freelance editor

Enago

March 2017 - July 2017

Clinical Research Fellow

University of North Carolina at Chapel Hill

October 2016 - June 2017

Clinical Research Fellow

University of North Carolina Hospitals

August 2016 - October 2016

Regulatory Affairs Intern

Chiesi Pharmaceuticals Inc

August 2016 - October 2016

Post-doctoral Research Associate Fellow

North Carolina State University

August 2014 - July 2016

Post-doctoral Research Fellow

Wake Forest School of Medicine

February 2011 - July 2014

Graduate Research Assistant

University of Nevada Reno

February 2006 - December 2010

Education

Medical Product Safety and Pharmacovigilance Certificate

Durham Technical Community College

2017 - Present

Data Management Certificate

Durham Technical Community College

2017 - Present

Ph.D in Cellular and Molecular Biology

University of Nevada Reno

January 2006 - December 2010

Licenciatura en Biotecnologia (Equivalent to a Master In Biotechnology)

Universidad Nacional de Rosario Facultad de Ciencias Bioquimicas y Farmaceuticas

March 1996 - April 2005

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Vance, M., Llanga, T., Bennett, W., Woodard, K., Murlidharan, G., Vance, M., Llanga, T., Bennett, W., Woodard, K., Murlidharan, G., et al.(2016). AAV Gene Therapy for MPS1-associated Corneal Blindness . Scientific Reports. 6.
(2014). Evaluation of gene delivery strategies to efficiently over-express functional hla-G on human bone marrow stromal cells. Molecular Therapy.
(2014). Perivascular stromal cells as a potential reservoir of human cytomegalovirus . American Journal of Transplantation. 14. (4). p. 820-830.
Soland, M.A., Bego, M., Colletti, E., Zanjani, E.D., St. Jeor, S., Porada, C.D., Almeida-Porada, G.(2013). Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage . PLoS ONE. 8. (3).
Almeida-Porada, G., Soland, M., Boura, J., Porada, C.D.(2013). Regenerative medicine: Prospects for the treatment of inflammatory bowel disease . Regenerative Medicine. 8. (5). p. 631-644.
(2013). Mesenchymal stem cells contribute to endogenous FVIII: C production . Journal of Cellular Physiology. 228. (5). p. 1010-1016.
BOOK CHAPTER
(2015). AAV Biology, Infectivity and Therapeutic Use from Bench to Clinic . Gene Therapy Principles and Challenges.